109 related articles for article (PubMed ID: 18380911)
1. Gene therapy for osteosarcoma: steps towards clinical studies.
Dass CR; Choong PF
J Pharm Pharmacol; 2008 Apr; 60(4):405-13. PubMed ID: 18380911
[TBL] [Abstract][Full Text] [Related]
2. Making gene therapy for osteosarcoma a reality.
Broadhead ML; Clark JC; Choong PF; Dass CR
Expert Rev Anticancer Ther; 2010 Apr; 10(4):477-80. PubMed ID: 20397911
[No Abstract] [Full Text] [Related]
3. Osteosarcoma treatment: state of the art.
Ta HT; Dass CR; Choong PF; Dunstan DE
Cancer Metastasis Rev; 2009 Jun; 28(1-2):247-63. PubMed ID: 19214708
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral-mediated gene transfer of ectodysplasin-A2 results in induction of apoptosis and cell-cycle arrest in osteosarcoma cell lines.
Chang B; Punj V; Shindo M; Chaudhary PM
Cancer Gene Ther; 2007 Nov; 14(11):927-33. PubMed ID: 17693991
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma: current status of immunotherapy and future trends (Review).
Mori K; Rédini F; Gouin F; Cherrier B; Heymann D
Oncol Rep; 2006 Mar; 15(3):693-700. PubMed ID: 16465432
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
Lamoureux F; Trichet V; Chipoy C; Blanchard F; Gouin F; Redini F
Expert Rev Anticancer Ther; 2007 Feb; 7(2):169-81. PubMed ID: 17288528
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.
Lamoureux F; Picarda G; Garrigue-Antar L; Baud'huin M; Trichet V; Vidal A; Miot-Noirault E; Pitard B; Heymann D; Rédini F
Cancer Res; 2009 Jan; 69(2):526-36. PubMed ID: 19147566
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy in the management of oral cancer: a review of recent developments.
Ladeinde AL; Ogunlewe MO; Adeyemo WL; Bamgbose BO
Niger Postgrad Med J; 2005 Mar; 12(1):18-22. PubMed ID: 15827591
[TBL] [Abstract][Full Text] [Related]
9. Non-viral methods for gene transfer towards osteosarcoma therapy.
Dass CR; Choong PF
J Drug Target; 2007 Apr; 15(3):184-9. PubMed ID: 17454355
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis.
Novak RL; Phillips AC
Cancer Gene Ther; 2008 Nov; 15(11):713-22. PubMed ID: 18551146
[TBL] [Abstract][Full Text] [Related]
11. Cancer gene therapy: an awkward adolescence.
Gottesman MM
Cancer Gene Ther; 2003 Jul; 10(7):501-8. PubMed ID: 12833130
[TBL] [Abstract][Full Text] [Related]
12. Gene-modified bone marrow cell therapy for prostate cancer.
Wang H; Thompson TC
Gene Ther; 2008 May; 15(10):787-96. PubMed ID: 18385769
[TBL] [Abstract][Full Text] [Related]
13. A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Sep; 30(27):4815-23. PubMed ID: 19505719
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy: applications and progress towards the clinic.
Trent RJ; Alexander IE
Intern Med J; 2004 Nov; 34(11):621-5. PubMed ID: 15546456
[TBL] [Abstract][Full Text] [Related]
15. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity.
Zhang HJ; Yang JJ; Lu JP; Lai CJ; Sheng J; Li YX; Hao Q; Zhang SM; Gupta S
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):672-8. PubMed ID: 19296158
[TBL] [Abstract][Full Text] [Related]
16. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
Pringle IA; Hyde SC; Gill DR
Expert Opin Biol Ther; 2009 Aug; 9(8):991-1003. PubMed ID: 19545217
[TBL] [Abstract][Full Text] [Related]
17. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
Ketola A; Hinkkanen A; Yongabi F; Furu P; Määttä AM; Liimatainen T; Pirinen R; Björn M; Hakkarainen T; Mäkinen K; Wahlfors J; Pellinen R
Cancer Res; 2008 Oct; 68(20):8342-50. PubMed ID: 18922906
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial design for adenoviral gene therapy products.
Shirakawa T
Drug News Perspect; 2009 Apr; 22(3):140-5. PubMed ID: 19440556
[TBL] [Abstract][Full Text] [Related]
20. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
